Key result
Transcatheter edge-to-edge repair (TEER) is a safe and effective treatment for patients with primary and secondary mitral regurgitation, requiring adequate preprocedural imaging for optimal patient selection.
Why the study?
Mitral regurgitation is common with many patients unsuitable for surgery, making adequate patient selection via clinical assessment and imaging essential for successful transcatheter edge-to-edge repair.
This review highlights the importance of adequate patient selection through clinical assessment and imaging modalities for successful mitral transcatheter edge-to-edge repair.
Mitral regurgitation (MR) is one of the most common valvular heart diseases, with many patients remaining non-suitable for surgical interventions. Transcatheter edge-to-edge repair (TEER) is a rapidly evolving procedure that allows safe and effective reduction of MR in high-risk patients. However, adequate patient selection through clinical assessment and imaging modalities remains a key factor for procedural success. In the following review, we highlight recent developments in TEER technologies that are expanding the target population and currently available imaging modalities that allow detailed evaluation of the mitral valve and surrounding structures for optimal patient selection.
No takes yet. Share an insight, caveat, or question.
Layoun et al. (2023) conducted a review in Mitral regurgitation. Transcatheter edge-to-edge repair (TEER) was evaluated. Transcatheter edge-to-edge repair (TEER) is a safe and effective treatment for patients with primary and secondary mitral regurgitation, requiring adequate preprocedural imaging for optimal patient selection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: